Background: One of the most common complications of diabetes in the lower extremity is the diabetic foot ulceration (DFU). Objective: To identify the determinants of the risk for diabetic foot ulceration (DFU) in terms of peripheral neuropathy (PN) or peripheral vascular disease (PVD) among a sample of diabetic foot patients. Methods: A cross sectional study included 100 diabetic foot patients attending Sohag University Hospital for follow up during the period from January 2009 to January 2010. They were subjected to complete medical history taking and thorough clinical examination. Diabetic Neuropathy Symptoms (DNS) along with the Diabetic Neuropathy Examination (DNE) scores were used together to define and assess PN. PVD diagnosis was based on identification of claudication pain symptoms; absent or weak foot pulses on palpation of the dorsalis pedis and/or the tibialis posterior arteries; coldness of skin; and finally confirmed by arterial doppler of lower limbs. Results: The mean age of the patients was 57.92 ± 9.2 years; 65% were males and 79% lived in rural areas. The majority (79%) had type 2 DM with mean disease-duration of 13.4 ± 6.9 years. Fifty percent of the study patients were smokers and ex-smokers, 33% were hypertensive and 24% had previous history of foot ulceration or amputation. Male gender, old age, low socioeconomic status, smoking, hypertension, type 2 DM, long duration of DM, uncontrolled DM, and previous history of foot ulceration, amputation or other diabetic complications were all significant determinants of PN and PVD; two major risk factors of DFU.
INTRODUCTION
Knowledge of diabetes dates back to centuries before Christ. (1) Diabetic foot is an umbrella term for foot problems in patients with diabetes mellitus (DM). Infection and/or gangrene of the foot are relatively common in diabetic patients due to arterial insufficiency, diabetic neuropathy and delayed wound healing. Diabetic foot is responsible for up to 50% of diabetes related hospital admissions. (2) Diabetic foot ulcer (DFU) is one of the common but often neglected complications of diabetes. There is no doubt that people with 692 Bull High Inst Public Health Vol.40 No. 4 [2010] DFU have considerable mortality and morbidity. The risk of death for those with foot ulcers is 12.1 per 100 persons per year-years of follow-up compared to 5.1 in those without foot ulcers. (3) Similarly, the risk for amputation in patients with diabetes is 15 times greater than that for the non-diabetic population and the majority of amputations are preceded by DFU. In addition to increased morbidity and mortality, patients with DFU have a poorer quality of life in comparison to those without ulcers. (4) Recent studies have revealed that interacting complex mechanisms are involved in the pathogenesis of DFU.
There is defective normal healing processes of the tissues. (5) Many chemo-cytokines are involved, including matrix metalloproteinases, serine proteinases, integrins, chemokines, replicative cell senescence, growth factors and adult stem cells. (6) Diabetic patients with tissue injury initially display impairment in the immune system response with reduced chemotactic effects to recruit inflammatory cells into the damaged tissues, thus, slowing down healing and increasing the risk of bacterial infection. (7) Following this initial period, the process switches to an exacerbation of inflammation and proteolysis. (8) The result of prolonged exposure to hyperglycemia also generates glycation of proteins and disturbances of cell responses, thus, further hindering the process of fibrosis and tissue repair. (9) Infection is usually the consequence rather than the cause of diabetic foot ulcers. Infected chronic ulcers may be classified as mild to moderate or severe, when osteomyelitis is involved. (10) One of the most common complications of diabetes in the lower extremity is the DFU. It is estimated that 15% of patients with diabetes will develop a lower extremity ulcer during the course of their disease. (11) While most ulcers can be successfully treated in the office or outpatient setting, infected and/or ischemic foot ulcers are a major cause for diabetes related hospitalization. (12) In the United States, the total costs for both direct and indirect health care for persons Alsenbesy et al.
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with diabetes in 1997 has been estimated to be $98 billion. Costs for ulcer care have been estimated to lie within the range of $4,595 per ulcer episode to nearly $28,000 for the 2 years after diagnosis. (13) The estimated overall total costs in the United States for diabetic foot disease can approach or exceed $6 billion annually. (14) Egypt is currently among the top 10 countries with the highest prevalence of diabetes and will remain so as 7.6 million Egyptians will have the disease by 2025. (15) In general, few studies have reported the prevalence of diabetic foot ulceration (DFU) as part of diabetes-related complications and, to our knowledge; there have been very few surveys on DFU risk factors in Egypt.
Mild foot ulcers precede most of the nontraumatic amputations in people with diabetes.
According to the International Diabetes
Federation and the International Working
Group on the Diabetic Foot, (14) it is possible to reduce amputation rates by between 49% and 85% through a care strategy that combines:
prevention; the multi-disciplinary treatment of foot ulcers; appropriate organization; close monitoring; and the education of people with diabetes and healthcare professionals. (16) Thus, it is essential that foot care services, which are very scarce in Egypt, be urgently initiated to cope with the rapidly increasing prevalence of diabetes and its complications among Egyptians.
The aim of the present work was to identify the determinants of the risk for DFU in terms of peripheral neuropathy (PN) or peripheral vascular disease (PVD) among a sample of diabetic foot patients in Sohag University Hospital.
SUBJECTS AND METHODS
A cross-sectional study included 100 patients diagnosed with diabetic foot and 1. Structured interview questionnaire to collect the following data:
• Name, age, sex, occupation, marital status, residence, and history of smoking.
• Type of diabetes, duration of diabetes, therapeutic history and diabetic control.
• Presence of vascular symptoms such as cramps and/or claudication and neuropathic symptoms such as tingling, numbness, and burning sensation with a 'stocking and glove' distribution.
• 
Data analysis
Data were computed and analyzed using 
RESULTS
The study included 100 patients with diabetic foot. The mean age of the patients was 57.92 ± 9.2 years; 63% were above the age of 55 years. Most of the sample were males (65%). More than one third of the samples (35%) were farmers, about 37%
without certain job, 14% were workers and 14% were employees. About 79% of the sample were rural residents and 21% of them were urban ones. The governorates and towns were considered as urban areas while the villages and hamlets were considered as rural areas. Table 1 shows that current smokers constituted 41% of the studied patients with diabetic foot, while ex-smokers rated 9%. Half of the sample were ever smokers. All females in the study were non-smokers while 76.9% of males were ever smokers. of the studied sample who received treatment for ischemic heart disease, while 4% of cases suffered from diabetic nephropathy and 2% suffered from diabetic retinopathy ( Table 5) .
Results of the present work showed that most of the sample (58%) had fasting blood glucose level ranging from 130 to 249 mg/dl, 26% had fasting blood glucose level of 250-399 mg/dl, while 4% had fasting blood glucose level >400 mg/ dl.
Fifty five percent of the total studied sample had diabetic neuropathy which was diagnosed according to DNS and DNE scores. Nearly one quarter of the studied diabetic foot patients (24%) had PVD. Long duration of DM was highly significantly associated with PVD (p=0.001), 75% of cases had duration of diabetes more than 10 years.
Only 3% of cases of the studied sample received prior foot care knowledge, all of them were employees and living at urban areas. No one of the studied sample had history of previous usage of therapeutic footwear. (16) Identifying diabetic patients at risk for DFU is very important in preventing this common and serious complication of diabetes and to decrease its effect on diabetic patients and the community in general. (17) This study has been conducted to identify two major risk factors of DFU namely; PN and PVD and their determinants. The studied sample showed that 55%, 24% and 1% had diabetic PN, PVD and previous history of foot ulcer respectively. These results when compared to data from near-by countries show that, the situation in Egypt seems to be alarming. In one study in the Gulf area, the prevalence of neuropathy, PVD and foot ulcer was found to be 36.6%, 11.8% and 5.9%
respectively. (17) The lower prevalence of ulcers in our study could be explained by the late presentation of the cases and the lack of welldeveloped foot care programs.
In general few studies were done to assess the risk factors of diabetic foot in Egypt and the world. This is the first study conducted in our university to assess and evaluate sociodemographic and medical factors that determine the risk for DFU in terms of PN and PVD.
The present study revealed that about 65%
of the study population were males. Male gender predominance was consistent with many earlier studies as that of Emad et al, for diabetic foot in our community. (19) People at greatest risk of diabetic foot complications can easily be identified by careful clinical examination of the feet so, education and frequent follow-up is indicated for these patients. (20) Diabetic foot ulcers is a leading cause of amputations, affect 15% of people with diabetes. (21) Thanks to foot-care programs, the incidence of diabetic foot amputation is decreasing in developed countries and was found to be 2.4 per 1000 diabetes-patients in Norway. (21) Conclusively, male gender, old age, low socioeconomic status, type 2 DM, smoking, hypertension, increased duration of DM, previous history of foot ulceration, amputation or other diabetic complications, uncontrolled DM, were main determinants of the risk for DFU as evidenced by two major risk factors namely diabetic neuropathy and PVD.
Awareness of the determinants of the risk for DFU is an inevitable step on the way to achieve a competent Foot-care system for diabetic patients in our community that would decrease morbidity and mortality, as well as, the economic burden in Egypt.
